- Home
- CSTL vs NVRI Comparison
CSTL vs NVRI Comparison
Compare CSTL & NVRI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CSTL
- NVRI
- Stock Information
- Founded
- CSTL 2007
- NVRI 1853
- Country
- CSTL United States
- NVRI United States
- Employees
- CSTL N/A
- NVRI N/A
- Industry
- CSTL Medical Specialities
- NVRI Diversified Commercial Services
- Sector
- CSTL Health Care
- NVRI Miscellaneous
- Exchange
- CSTL Nasdaq
- NVRI Nasdaq
- Market Cap
- CSTL 576.3M
- NVRI 521.3M
- IPO Year
- CSTL 2019
- NVRI N/A
- Fundamental
- Price
- CSTL $19.78
- NVRI $6.71
- Analyst Decision
- CSTL Strong Buy
- NVRI Hold
- Analyst Count
- CSTL 6
- NVRI 1
- Target Price
- CSTL $40.00
- NVRI $10.00
- AVG Volume (30 Days)
- CSTL 403.1K
- NVRI 1.2M
- Earning Date
- CSTL 05-01-2025
- NVRI 05-01-2025
- Dividend Yield
- CSTL N/A
- NVRI N/A
- EPS Growth
- CSTL N/A
- NVRI N/A
- EPS
- CSTL 0.62
- NVRI N/A
- Revenue
- CSTL $332,069,000.00
- NVRI $2,342,645,000.00
- Revenue This Year
- CSTL N/A
- NVRI N/A
- Revenue Next Year
- CSTL $6.01
- NVRI $3.86
- P/E Ratio
- CSTL $32.29
- NVRI N/A
- Revenue Growth
- CSTL 51.09
- NVRI N/A
- 52 Week Low
- CSTL $16.97
- NVRI $5.67
- 52 Week High
- CSTL $35.84
- NVRI $12.79
- Technical
- Relative Strength Index (RSI)
- CSTL 36.62
- NVRI 45.41
- Support Level
- CSTL $19.22
- NVRI $6.59
- Resistance Level
- CSTL $20.30
- NVRI $7.22
- Average True Range (ATR)
- CSTL 0.81
- NVRI 0.32
- MACD
- CSTL 0.23
- NVRI 0.10
- Stochastic Oscillator
- CSTL 43.33
- NVRI 56.78
About CSTL Castle Biosciences Inc.
Castle Biosciences Inc is a commercial-stage dermatological cancer company. It is focused on providing physicians and their patients with personalized, clinically actionable genomic information to make more accurate treatment decisions. The product portfolio of the company includes Cutaneous Melanoma, DecisionDx-Melanoma, DecisionDx-CMSeq, and DecisionDx-PRAME, among others. The company's test portfolio consists of test offerings to aid clinicians in the diagnosis and treatment of cancers or precancerous diagnoses in the fields of dermatology, gastroenterology, and ophthalmology and a pharmacogenomics ("PGx") test to guide optimal drug treatment for patients diagnosed with depression, anxiety, and other mental health conditions.
About NVRI Enviri Corporation
Enviri Corp is a market-leading, provider of environmental solutions for industrial and specialty waste streams, and equipment and technology for the rail sector. The company's current operations consist of three divisions: Harsco Environmental, Harsco Rail, and Clean Earth. The company gains its revenue from Harsco Environmental segment. Geographically company operates in USA and International Countries, with majority revenue from USA.